European guidelines mention permethrin, benzyl benzoate and crotamiton as topical antiscabiosa. There have been repeated reports of treatment failure with permethrin in recent years, although the causes are controversial. In order to directly compare permethrin 5% with benzyl benzoate 25%, an Austrian research team conducted a double-blind randomized study.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Study report
Scabies treatment: benzyl benzoate in direct comparison with permethrin
- Innovative approaches in glioblastoma treatment
Synergistic combination therapies and the potential of phytotherapy and mycotherapy
- Acute heart failure
Diuretic therapy for decongestion – what are the “unmet needs”?
- Association of polyps and colorectal cancer
Caution with a family history
- Development of type 1 diabetes
Early use of antibiotics can promote T1D
- Psoriasis
Indications of an increased risk of “leaky gut”
- Characteristics, prognosis and different evolutionary paths
Progression of chronic heart failure
- SGLT2 inhibitors and GLP1-RA